Postgraduate Course

The Microbiome and Its Role in IBS

Speaker(s)

• 

  Mark Pimentel, MD, FACG

  Executive Director, MAST Program
  Cedars-Sinai
  Los Angeles, CA

  Advisory Committee/Board Member: Gemelli Biotech, Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
  Consultant: Allergan, Naia Pharmaceuticals, Salix Pharmaceuticals, Shire, Synthetic Biologics, US Medical
  Grant/Research Support: Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
  Patent Holder: Gemelli Biotech, Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
  Stockholder/Ownership Interest (excluding diversified mutual funds): Gemelli Biotech, Synthetic Biologics
  Cedars-Sinai Medical Center has a licensing agreement with Naia Pharmaceuticals, Salix Pharmaceuticals, Gemelli Biotech, and Synthetic Biologics.: Other

Learning Objectives:

• Identify the role of the microbiome in IBS.